<DOC>
	<DOCNO>NCT00004474</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare outcome , include graft failure , graft versus host disease , survival HLA-identical sibling bone marrow transplant aplastic anemia use cyclophosphamide without antithymocyte globulin condition regimen .</brief_summary>
	<brief_title>Phase III Randomized Study Cyclophosphamide With Without Antithymocyte Globulin Before Bone Marrow Transplantation Patients With Aplastic Anemia</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , multicenter study . Patients randomize receive cyclophosphamide IV 60 minute day -5 -2 without antithymocyte globulin IV 4 hour . All patient receive bone marrow 60-120 minute day 0 , 36 hour last dose cyclophosphamide . Patients follow day 100 , 6 month , 1 year posttransplant .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Severe aplastic anemia follow criterion : Hypocellular bone marrow cellularity le 20 % At least 2 follow hematologic abnormality : Neutrophil count great 500/mm3 Platelet count great 20,000/mm3 Reticulocyte count great 50,000/mm3 HLAidentical sibling donor available No clonal cytogenetic abnormality , paroxysmal nocturnal hemoglobinuria , myelodysplastic syndrome within 3 month diagnosis aplastic anemia No congenital constitutional aplastic anemia Fanconi anemia Patient Characteristics Hepatic : Bilirubin le 3 time upper limit normal ( ULN ) Renal : Creatinine le 2 time ULN Cardiovascular : Normal cardiac function Other : No uncontrolled infection No severe concurrent disease HIV negative Fertile patient must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Hematologic Disorders</keyword>
	<keyword>Rare Disease</keyword>
</DOC>